Marinus Pharmaceuticals, Inc.
MRNS · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$24 | -$36 | -$39 | -$42 |
| Dep. & Amort. | -$1 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $1 |
| Stock-Based Comp. | $5 | $5 | $5 | $4 |
| Change in WC | -$1 | -$3 | -$6 | $10 |
| Other Non-Cash | $2 | $3 | $9 | -$1 |
| Operating Cash Flow | -$19 | -$31 | -$37 | -$27 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$0 | $0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | -$0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $9 | $21 | $7 |
| Other Inv. Act. | $0 | $0 | $21 | $7 |
| Investing Cash Flow | -$1 | $9 | $21 | $6 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$2 | $0 | $0 | $1 |
| Stock Issued | -$0 | $0 | $0 | -$0 |
| Stock Repurch. | $0 | $0 | $0 | -$0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$18 | $0 | $0 |
| Financing Cash Flow | -$2 | -$18 | $0 | $1 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$22 | -$40 | -$16 | -$20 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $65 | $104 | $121 | $140 |
| End Cash | $42 | $65 | $104 | $121 |
| Free Cash Flow | -$21 | -$31 | -$37 | -$27 |